TNeuroPharma
Albuquerque · Founded 2018
About TNeuroPharma
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease. Its technology helps to target the dysfunctional t-cells which helps in detecting Alzheimer's disease through the use of blood samples, enabling patients to detect and treat the disease at the early stage and to prevent any complications in the future. The company was founded in 2018 and is based in Albuquerque, New Mexico.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $25.0K
- Funding stage: Seed
- Last round: Grant (Mar 2022)
- Website: https://tneuropharma.com/
- Phone: 575.644.1361
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/tneuropharma-176089 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.